preparations of vasopressor therapies, 2 push-dose preparations and a peripheral continuous infusion. PDPs were prepared according to 2 techniques. The first is a "dirty" preparation utilizing a saline flush and cardiac epinephrine syringes, physically mixing the 2-in-1 syringe. The second method of preparation is a best practice according to the Institute for Safe Medication Practices (ISMP) and utilized bacteriostatic normal saline and cardiac epinephrine syringes for admixture. Norepinephrine infusions were compounded to have a final concentration of 4mg/ 250mL. Physicians (including both ED residents and attendings) were not asked to prepare an IV infusion, due to their limited familiarity with IV pumps. The timer was initiated on a count down and was stopped when the vasopressor therapy had been successfully administered through an IV line in a mannequin arm. After the completion of all 3 preparations, a survey was completed recording participants' professions, preferred method of preparation and years of job experience.
Study Objectives: Chest tube thoracostomy is a low frequency, high stress, lifesaving procedure. Although non-cadaveric commercial trainers are available, their procurement and maintenance can be financially prohibitive. We designed and fabricated a trainer that contains enough structural detail to perform all of the steps of the procedure, is inexpensive, and easy to use and reuse.
Methods: We used a 4-foot, 16-inch diameter hollow cardboard concrete tube mounted horizontally on a wooden base for the body of the trainer. A grouping of 2 parallel slats was cut into the tube, representing ribs and intercostal spaces. A total of 4 such groupings were made to create 4 workstations, 2 on each end of the tube form opposite one another. Small sheets of craft foam were placed over the slats to represent subcutaneous tissue and muscle. Microfoam tape was applied over the craft foam and to the inner surface of the slats to serve as the skin and the pleura, respectively. At each workstation, up to 4 chest tubes could be inserted before the craft foam and microfoam tape needed to be replaced. All learners were given instruction by an emergency medicine attending and then given time for supervised practice with feedback.
Results: The trainer was used by 36 different learners during intensive procedure labs, all over a 1.5-year period. The procedure was estimated to be performed 312 times. Learners were able to perform/experience all critical steps of the procedure (eg, palpate intercostal spaces, feel the "pop" of the pleura, suture the chest tube into place, etc) except for using axilla, nipple, or inframammary fold as anatomical landmarks. All learners stated they felt more comfortable performing the procedure and understood the steps, though this was not rigorously measured. The tube itself did not incur significant wear. Four learners could work on the trainer at the same time, and then could easily reset the trainer (in minutes) for the next repetition. The cost for construction of the body of the trainer (concrete tube form, wood base, and screws) was $26. The cost for microfoam tape and craft foam was $24 and $10, respectively. This comes out to about $0.20 per chest tube insertion.
Conclusions: Our appropriately designed low fidelity trainer can provide an inexpensive and easy-to-use and reuse platform for learning chest tube thoracostomy. The trainer provided enough detail to perform the procedure and was sturdy enough for hundreds of uses by multiple users, with minimal wear. Future study should be done in this area to compare low fidelity versus high fidelity trainers for procedural knowledge acquisition. Methods: Using systematic time-block sampling, we prospectively enrolled 130 patients, age 55, returning to the ED of a large urban safety-net hospital within 30 days of an index visit. Demographics, medical history, pain scores, number of returns within 30 days, disposition, mode of arrival, and REALM Health Literacy scores (low REALM, 8 th grade reading level) were collected. Patients' socioeconomic disadvantage was measured using Area of Deprivation Index with American Community Survey 2011-2015 census data. Minimum clinically significant difference (MCSD) in pain scores were calculated using a difference of 2. Pearson's Chi-square, Fisher's exact, and Wilcoxon rank sum tests were performed for categorical and continuous data. Significant predictors for returns were determined using multiple logistic regressions with backward variable selection method and the goodness of fit using the Residual Chi-square score statistic. All analyses were done in SAS for Windows Version 9.4.
Results: Of the 130 patients, most returned for pain (PG, Pain Group) (74, 57%), were black (78%), 55-64 years old (67%), had a high acuity level (level 1 or 2) at their index visit (56%), a low REALM score (62%), arrived by non-medical transport (72%) to their index visit, lived in an area of extreme deprivation (69%), and were admitted (61%) during their index visit (Table 1 ). The average number of ED returns 30 days post index visit was 1.8. Both groups reported similar reasons for returning: worsening/ progression of symptoms (50%), new problem (24%), and a medication issue (13%).
Compared to the Non-PG, the PG was younger (p ¼ 0.014), had higher pain scores at their index visit (median 8.5, quartile 5.5, 10, p ¼ 0.0002) with a little over half achieving a MCSD in their index visit pain scores (57%). In the PG, 61% (45) reported home opioid use at the index visit and 31% (14) received another opioid prescription. Of the 17 in the PG discharged with an opioid (23%), 13 returned for worsening symptoms and 4 for medication issues. Compared to the PG, more patients in the Non-PG were admitted (74%, p ¼ 0.018), had low REALM scores (75%, p ¼ 0.005), and presented with a respiratory chief complaint at their index visit (p ¼ 0.004). Socioeconomic disadvantage, sex, ethnicity, index visit mode of arrival, and insurance type was not significantly different between groups. As continuous variables, age (p ¼ 0.016), index visit pain scores (p ¼ <0.001), and index visit acuity (p ¼ 0.028) were significantly different between groups. Age (OR 0.9, 95% CI 0.8-0.9, p ¼ 0.047), REALM scores (OR 3.1, 95% CI 1.3 -7.5, p ¼ 0.011), and index visit pain scores (OR 1.1, 95% CI 1.0-1.2, p ¼ 0.004) were predictive of ED returns for pain in older adults.
Conclusions: The likelihood of returns for pain in older adults decreased with age; increased with higher REALM scores; and increased by 10% for each point increase in pain scores. Study Objectives: Benzodiazepine use in the older adults has been associated with a myriad of adverse effects such as delirium, mechanical fall, fractures, and memory disturbances. Despite their particular risk to this population, there is a concern regarding the frequency of benzodiazepine use in US emergency departments (EDs). In this study we utilize national databases to describe trends in utilization of benzodiazepines in the older adult population.
Methods: Data from the CDC's 2005-2015 National Hospital Ambulatory Medical Care Survey (NHAMCS) were compiled and analyzed. Variables were created to identify all patients aged over 60 years who had been administered benzodiazepines and subsequently been given a diagnosis of delirium. Appropriate bivariate statistical analyses and multivariate regression modeling were subsequently utilized.
Results: During study period approximately 250 million adults aged over 60 were seen in US EDs, 10.2 million of which (4.1%) were administered a benzodiazepine. The rate of administration ranged from 3.6% in 2005 (95% CI 3.1-4.3) to 4.5% in 2015 (95% CI 3.7-5.6). This represented a relative change of +25% over the study period. Older adults given benzodiazepines during their ED course were significantly more likely to be diagnosed with delirium (8.5% 95% CI 5.4-13.2% P¼0.001) compared to those who did not (4.1 95% CI 3.9-4.4 P<0.0001) and were also more likely to be admitted to the hospital (34.9% versus 29.9%). Older adults administered benzodiazepine also exhibited high rates of depression (15.7% 95% CI 11.8-20.1 P¼0.002). Results of multivariate regression modeling indicated that when patient demographics and medical history are accounted for, older adults given benzodiazepines demonstrated an increased odds of being diagnosed with delirium (aOR 2.2 95% CI 1.6-4.1 P<0.0001) an increased odds of being admitted to the hospital (aOR 1.4 95% CI 1.1-1.8 P<0.0001) and to have also been administered an opioid analgesic in the ED (aOR 1.7 95% CI 1.5-1.9 P<0.0001). Older adults administered benzodiazepines were more likely to be male (aOR 1.2 95% CI 1.0-1.3), to have a history of stroke (aOR 1.2 95% CI 1.04-1.6) or coronary artery disease (aOR 1.4 95% CI 1.1-1.7 P<0.0001).
Conclusions: Despite the risks associated with the administration of benzodiazepines to older adults, this population still demonstrates heightened and increasing levels of utilization. Older adults administered these agents exhibited higher rates of depression and delirium as well as an increased likelihood of being admitted to the hospital. Study Objectives: 209,000 people suffer an in-hospital cardiac arrest (IHCA) in the US every year. Prior research suggests advance directives are rarely completed among high-risk populations. No data exist about advance directive completion in sudden IHCA victims. Among these patients, we sought to determine the percentage that had completed a pre-arrest advance directive, the percentage who expressed their wishes to not be resuscitated prior to their cardiac arrest (DNR), and the percent that re-addressed their code status following return of spontaneous circulation (ROSC).
Methods: Retrospective chart review at a single, 927-bed academic medical center. Adults in whom a "code blue" was called between January 2017 and March 2018, and had a confirmed cardiac arrest, were included. Cardiac arrests with incomplete data or that occurred in the ED or ICU were excluded. Trained and supervised research assistants used a standardized data collection tool to extract event related data from the electronic and paper medical record. Admission history and physical, "code blue sheets," progress notes up to 24 hours after the event, discharge summaries, death summaries and all advance directive notes, including advance directives, living wills, durable power of attorney documents, code status orders written throughout the admission were reviewed. Physician orders for life-sustaining treatment documents were not included.
Patients were considered to have a pre-arrest advance directive if the advance directive was scanned into the medical record or referenced by a member of the care team prior to sudden IHCA. Patients with pre-arrest DNR status were identified by documentation on the "code blue sheet" or in the notes in the 24h following the code indicated contact with power of attorney stating patient should have been DNR.
Patients were considered to have had their code status re-addressed prior to death or discharge if family meeting discussing code status was documented after the code, code status order was changed after the code, or code status was addressed in hospital summaries.
Standard descriptive statistics were used. Results: 188 code blues were identified of which 5 were excluded. Of the remaining 183, 71% were black, 17% were white; mean age 65 and 46% were women. 131 (71.6%) had ROSC; 55 (30%) survived to hospital discharge. 14 patients (7.7%) had a pre-arrest advance directive. Two patients (1.1%) were DNR prior to their arrest but had CPR performed. One of these patients had a pre-arrest advance directive stating DNR status, but inpatient code orders and physician documentation indicated full resuscitation. The other patient had a documented pre-arrest advance directive indicating power of attorney, and had code orders and physician documentation indicating full resuscitation; however, post-ROSC, the power of attorney indicated the patient expressed DNR wishes pre-arrest.
Eighty-five of the 131 patients with ROSC had their code status adjusted or confirmed either by themselves or family members prior to expiration or discharge. Only 2 patients completed new advance directives following the code.
